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Abstract
Human (h) embryonic stem cells (ESC) represent an unlimited source of cardiomyocytes (CMs); however, these
differentiated cells are immature. Thus far, gene profiling studies have been performed with non-purified or non-
chamber specific CMs. Here we took a combinatorial approach of using systems biology to guide functional
discoveries of novel biological properties of purified hESC-derived ventricular (V) CMs. We profiled the
transcriptomes of hESCs, hESC-, fetal (hF) and adult (hA) VCMs, and showed that hESC-VCMs displayed a unique
transcriptomic signature. Not only did a detailed comparison between hESC-VCMs and hF-VCMs confirm known
expression changes in metabolic and contractile genes, it further revealed novel differences in genes associated with
reactive oxygen species (ROS) metabolism, migration and cell cycle, as well as potassium and calcium ion transport.
Following these guides, we functionally confirmed that hESC-VCMs expressed IKATP with immature properties, and
were accordingly vulnerable to hypoxia/reoxygenation-induced apoptosis. For mechanistic insights, our coexpression
and promoter analyses uncovered a novel transcriptional hierarchy involving select transcription factors (GATA4,
HAND1, NKX2.5, PPARGC1A and TCF8), and genes involved in contraction, calcium homeostasis and metabolism.
These data highlight novel expression and functional differences between hESC-VCMs and their fetal counterparts,
and offer insights into the underlying cell developmental state. These findings may lead to mechanism-based
methods for in vitro driven maturation.
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Introduction
The innate regenerative capacity of the adult mammalian
heart is insufficient to restore function damaged by myocardial
injury or heart failure. The identification of stem or progenitor
cells that produce cardiomyocytes (CMs) has raised the
intriguing possibility of cell-based cardiac regenerative
therapies. Given the self-renewing capacity of pluripotent stem
cells and their ability to differentiate into the cardiac lineage
[1-6], human (h) embryonic stem cells (ESC) and induced
pluripotent stem cell (iPSC) represent a potentially unlimited
source of renewable CMs. However, hESC/iPSC-derived CMs
are most similar to those of fetal tissues, functionally and
structurally, and do not fully recapitulate post-natal or adult
phenotypes [5,7-10]. For instance, hESC/iPSC-CMs have
spontaneous contractile activities, express low levels of IK1, and
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relatively high currents from INCX and If [11]. Sarco/endoplasmic
reticulum (SR) function remains rudimentary, as the cells
exhibit a modest Ca2+ transient with slow kinetics, moderate SR
Ca2+ATPase (SERCA) levels, low and disorganized ryanodine
receptors and delayed phospholamban (PLN) expression [8,12]
without the T-tubule system [9]. To overcome these limitations,
an understanding of the molecular and cellular processes
responsible for the development of a more physiological adult-
like phenotype is required.
Microarray experiments have been performed to characterize
the transcriptome of hESC-CMs and to identify signaling
pathways implicated in their differentiation [13-17]. However,
most of these studies were complicated by the presence of
non-CMs in the cardiac biopsies and the use of un-staged and
pooled fetal or adult heart samples [17,18] and non-purified or
only partially purified ESC-CMs [13,14] without distinguishing
the chamber-specific types. The expression data generally
indicate that hESC-CMs express cardiac-specific genes, have
lower levels of contractile and metabolic genes, and show
differential expression of specific potassium/calcium ion
channels, consistent with and complementary to known
functional data. However, further functional analysis was often
not performed and mechanistic insights into the causes of the
immature state were lacking.
By studying a purified population of hESC-derived ventricular
(V) CMs (hESC-VCMs), as identified by the expression of a
reporter under the transcriptional expression of the MLC2v
promoter [19] and functionally confirmed by
electrophysiological assays, here we took a combinatorial
approach of using systems biology to guide functional
discoveries of novel biological properties of hESC-VCMs. We
performed microarray and bioinformatics analyses of staged
human (h) fetal (F, 18-20 weeks), adult (A) and hESC-derived
VCMs. As anticipated, our results show that hESC-VCMs have
a unique transcriptomic signature, contractility and metabolic
parameters that are most analogous to fetal cells; but, we also
discovered a range of novel changes in cell cycle, reactive
oxygen species (ROS) metabolism and migration that have not
been previously reported. Focused analysis on genes involved
in potassium and calcium ion transport further revealed novel
functional immaturity. These results are discussed in relation to
regulatory mechanisms.
Materials and Methods
Culture and isolation of undifferentiated hESCs and
hESC-VCMs
Undifferentiated HES2 (ES02, ESI International, Singapore)
were maintained at 37°C and 5% CO2 on irradiated mouse
embryonic fibroblasts. Cardiac differentiation was performed
using established protocols [20] (Methods S1). 20-30 days after
differentiation, cells were transduced with recombinant LV-
MLC2v-mCherry particles. Fluorescing mCherry-positive cells
were isolated 72 hours post-transduction by flow-activated cell
sorting (BD FACSAriaTM II). Resultant cells were >95% pure
and displayed ventricular action potentials.
No ethical approval was required for preparing the mouse
embryonic fibroblasts because the animals were sacrificed
without any prior manipulation. Mice were sacrificed by
pentabarbital.
Isolation of hF- and hA-VCMs
HF-VCMs and hA-VCMs were isolated and experimented
according to protocols approved by the UC Davis IUPAC and
IRB (Protocol 200614787-1 and # 200614594-1) (Table S1,
Methods S1).
Transcriptomic Profiling
Cell samples were lysed in Trizol (Invitrogen). After adding
1:4 volume chloroform, aqueous and organic phases were
separated. RNAs were extracted from the aqueous phase
using the miRNeasy kit (Qiagen, Valencia, CA). Sentrix 48kb
WG-6 beadchips (Illumina, San Diego, CA) were used to profile
mRNA expression. Microarray data were analyzed using the
BeadStudio transcriptomic (Illumina) software packages.
(Please see methods S1 for details)
Co-expression and promoter analyses
Pearson correlation coefficient (PCC) was used to compare
expression pattern across four groups of samples, hESCs,
hESC-VCMs, hF-VCMs and hA-VCMs (PCC>0.95). We
focused on 17 TFs including FOXP1, GATA4, GATA6, HAND1,
HAND2, IRX4, IRX5, ISL1, MEF2C, MESP1, NKX2-5, PPARA,
PPARGC1A, SRF, TBX20, TBX5, which have all been shown
to play important roles in the heart, as well as TCF8. Binding
sites of TFs GATA4, HAND1, NKX2-5 and TCF8 were
predicted using Genomatix MatInspector. The promoter region
between 1000 bp upstream and 300 bp downstream of 27
genes in the co-expression network was analyzed.
Hypoxia treatment and TUNEL assay
HESC-VCMs of 20-30 days post-differentiation were
subjected to hypoxia (1% O2)/reoxygenation for different
durations as stated. For hypoxia, hESC-VCMs were transferred
to a CO2 incubator with 95% N2/5% CO2 at 37°C. After hypoxia,
cells were transferred back to 95% air/5% CO2 for
reoxygenation. TUNEL assay was performed as per
manufacturer’s instructions (Roche Diagnostics).
Electrophysiology
Electrical recordings were performed using the whole-cell
patch-clamp technique as previously described [21,22] at 37°C.
For IKATP measurements, the internal pipette solution contained
(mM) potassium glutamate 120, KCl 25, ATP (magnesium salt)
1, EGTA 10, MgCl2 0.5, and HEPES 10 (pH 7.2). The external
bath solution contained (mM) NaCl 140, KCl 5, MgCl2 1, CaCl2
1, and HEPES 10 (pH 7.4) [21]. To induce hypotonic stress, a
modified Tyrode’s solution consisting of 64mM NaCl and 50mM
mannitol was superfused with a flow speed of 2ml/min to
replace the control solution consisting of 64mM NaCl and
150mM mannitol.
Optical Mapping
Transmembrane potential of hESC-VCM monolayers was
optically mapped by using MiCam Ultima (Scimedia, USA)
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fluorescence non-contact imaging system with a 1cm2 field-of-
view. Briefly, hESC-VCM preparations, which were cultured on
gelatin-coated glass coverslips, were incubated with 4-8µM
di-4-ANEPPS (Invitrogen, USA) for 20 min at room temperature
in Tyrode’s solution, consisting of (mM) 140 NaCl, 5 KCl, 1
MgCl2, 1 CaCl2, 10 D-glucose and 10 HEPES at pH 7.4.
Monolayers were rinsed twice with pre-warmed (37°C)
Tyrode’s solution before imaging using a halogen light, which
was filtered by a 515±35 nm band-pass excitation filter and a
590 nm high-pass emission filter. A co-axial point stimulation
electrode was used to deliver a steady-state pacing at 1 Hz, 8V
and 10ms pulse duration. Please see methods S1 for more
details.
Results
Isolation and characterization of hESC-VCM
We performed directed cardiac differentiation as described
previously [20] with cardiac derivatives making up ~50% of the
cell population (Figure 1A). HESC-VCMs were identified by the
expression of a reporter under the transcriptional control of the
MLC2v promoter [19] (Figure 1B) and were isolated by flow-
activated cell sorting. Resultant cells were >95% pure (Figure
1C) and displayed ventricular action potentials (Figure 1D).
HESC-VCMs displayed a unique transcriptional
signature and were less developmentally advanced
than hF-VCMs
We performed transcriptomic analyses of microarrays
containing 48,804 probes corresponding to 25440 genes.
Pluripotency genes such as POU5F1(Oct4) and NANOG were
highly expressed in hESCs but absent in all of hESC-, hF- and
hA-VCM samples. Conversely, cardiac markers such as MYL2,
TNNT2 and ACTN2 were specifically detected in the three
VCM populations, confirming their cardiac identities.
Hierarchical clustering and principal components analysis
(PCA) established that overall gene expressions among
biological replicates were very similar (Figure 1E and F). The
transcriptomic expression of hESC-VCM samples grouped
more similarly to hF-VCMs and hA-VCMs than to hESCs
(Figure 1F). The most conspicuous trend in global gene
expression was that genes of hESC-VCMs, hF-VCMs and hA-
VCMs on the PCA plot followed a virtually linear relationship
(Figure 1F) with hESC-VCM, hF-VCM, and hA-VCM group of
genes situated at the bottom left, middle and top right,
respectively, which is consistent with a progressive increase in
cellular maturity. A comparison between hESC-VCMs and hF-
VCMs showed that 1852 (7%) and 2195 (9%) genes were up-/
down-regulated by more than 2-fold in hESC-VCMs relative to
hF-VCMs respectively.
HESC-VCMs expressed significant levels of chamber-
specific genes similar to chamber myocardium, but
with a slower conduction velocity than hF-VCMs
We further assessed the developmental status of hESC-
VCMs by the use of molecular markers that are restricted to or
upregulated in chamber myocardium relative to the primitive
myocardium in human [23] and mice [24]. We detected
significant gene expression from NPPA (atrial natriuretic
factor), GJA1 (gap junction alpha-1/connexin 43), GJA5 (gap
junction alpha-5/connexin 40), SMPX(chisel) and
IRX5(Iroquis-5) (p<0.05) in hESC-VCMs; however, the
expression of GJA5, SMPX, and IRX5 in hESC-VCMs was
4.7-, 3.2-, and 2.4- fold lower than those in hF-VCMs. The data
showed that the hESC-VCMs displayed gene expression
profiles typical of early chamber myocardium, suggesting that
the cells were less developmentally advanced than the hF-
VCMs analyzed in this study. The general immaturity of hESC-
VCMs and more specifically the reduced expression of GJA5,
is also typical of very immature chamber myocardium, which is
known to have a very slow conduction velocity. Consistently,
optical mapping of purified hESC-VCM in monolayer culture
confirmed that the conduction velocity (5.0±1.4 cm/s) was
much slower than that of the intact adult human heart (7-80
cm/s depending on fibre direction) [25] (Figure 1G) but is
similar to that of non-purified hESC-CMs (5±6 cm/s) [11].
Furthermore, CX43-positive gap junctions are aligned at the
intercalated disc of adult CMs [26] but such was not the case
for hESC-VCMs, whose CX43-positive gap junctions were
randomly distributed (Figure 1H). Evidently, conduction pattern
was isotropic as opposed to anisotropic as observed in the
native myocardium [27].
Examination of the most abundant transcripts in CM
samples identified novel markers of cardiac maturation
The functions of the 200 most abundant transcripts in hESC-,
hF- and hA-VCMs were examined by Gene Ontology analysis
(Table S2). The three populations showed a high level of
similarity, with 101 common transcripts involving mostly
translation elongation (Figure 2A). HA- and hF-VCMs shared
43 transcripts enriched for muscle system, contraction and
energy generation, while hESC- and hF-VCMs shared only 31
involved in translational elongation. Transcripts involved in
energy generation were particularly abundant in hA-VCMs,
consistent with their high metabolism. We focused on heart-
specific genes to identify novel markers for CM identity and
maturation. Twenty-seven gene products were more than 10-
fold enriched in the heart and skeletal muscle, including known
cardiac markers such as MYL2, MYH7 and TNNC1 (Figure 2B
and C). Six genes (HSPB7, MYH7, MYL2, MYL7, NPPA and
TNNC1) were within the top 200 abundant genes in all three
CM samples and may serve as markers of cardiac identity. Ten
gene transcripts were more than 10-fold depleted in hESC-
VCMs relative to hF-VCMs and/or hA-VCMs. Of these, the
expression of CKMT2, SRL, CMYA5, ITGB1BP3, MYOM2 and
TCAP in hESC-VCMs have not been described previously.
CKMT2 is involved in energy generation. CMYA5, MYOM2 and
TCAP are structural genes while SRL encodes a Ca2+ binding
protein. ITGB1BP3 encodes an integrin beta 1 binding protein
with unknown function in the heart.
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Figure 1.  Developmental classification of hESC-VCMs.  A) A representative FACS plot showing that approximately 55% of
hESC-derivatives were positive for cardiac troponin-T (cTnT) prior to selection. B) Selected MLC2V-mCherry+ hESC-VCMs (~95%
purified) under brightfield and fluorescence microscopy (100x). C) Purified HESC-VCMs were stained with anti-cTnT and anti-α-
actinin antibodies. D) Representative action potential of hESC-VCMs. E) Hierarchical clustering showing that biological replicates
cluster together. Red and green indicates up- and down-regulation respectively. F) Principal Component Analysis. HESC-VCMs, hF-
VCMs and hA-VCMs lie along a linear developmental axis (dotted black line). Correlation coefficient is shown to indicate the degree
of linearity. G) An activation isochronal map of trans-membrane potential with 15ms intervals. H) CX43 staining of hESC-VCMs.
Red= CX43 staining, blue=DAPI.
doi: 10.1371/journal.pone.0077784.g001
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Figure 2.  The most abundant transcripts in VCM populations.  A) The Venn diagram shows the distribution of the top 200 most
abundant genes in hESC-VCMs, hF-VCMs and hA-VCMs. The number of genes in common is indicated. The labels refer to
biological processes that are enriched. B) The tissue-specific distribution of the top 200 genes was examined in public databases
including Genenote and bioGPS. The ‘cardiac-specific’ genes among the top 200 most abundant genes are shown. C) 27 cardiac-
specific genes within the top 200 most abundant genes in hESC-VCMs, hF-VCMs and/or hA-VCMs. Fold change relative to hESC-
VCMs are indicated and fold change >10 is highlighted in bold. Possible function is based on gene ontology association.
doi: 10.1371/journal.pone.0077784.g002
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Gene Set Enrichment Analysis (GSEA) reveals novel
expression differences in cell cycle, ROS metabolism
and migration
GSEA was employed to identify specific expression
differences between hF-VCMs and hESC-VCMs. We examined
1403 gene sets among 25440 genes and found that 119 (8%)
and 572 (41%) gene sets were significantly decreased and
increased in hESC-VCMs relative to hF-VCMs respectively.
The 50 most differentially expressed gene sets are
summarized in Table 1 and listed in Table S3A and S3B. QRT-
PCR analysis was performed on selected genes to verify the
microarray data (Figure S1).
Consistent with previous reports, gene sets related to
respiration, tricarboxylic acid (TCA) cycle, fatty acid oxidation
and heart development were decreased in hESC-VCMs
compared to hF-VCMs [17]. Of expression changes that have
not been previously described, cell cycle-related gene sets
showed the most significant decrease in expression in hESC-
VCMs, with extremely low false discovery rate (FDR) scores of
<0.0001. They were also the most abundant, totaling 20 out of
50 top most reduced gene sets. These gene sets
encompassed various stages including G1-M phases and
cytokinesis, suggestive of inhibition at multiple stages of the
cell cycle. Cycling cells require mechanisms to preserve
genomic integrity during DNA replication and we detected
lower level of genes associated with telomere maintenance,
consistent with the decreased level of cell cycle genes. Genes
involved in ROS metabolism were down-regulated in hESC-
VCMs. In particular, catalase (CAT) and glutathione peroxidase
(GPX3) are important for ROS removal and both were found at
low and significantly reduced levels (10- and 5-fold
respectively) in hESC-VCMs compared to hF-VCMs. ROS
plays an important role in the induction of apoptosis and
expression of apoptotic genes were also enhanced in hESC-
VCMs.
There was an increased expression of genes associated with
cell migration, in 11 out of the top 50 gene sets. Examples
included pro-migratory proteases and receptors e.g., THBS1,
F2RL1, and SPHK1, signaling molecules TGFB2 and BMP2,
and matrix metalloproteinase MMP9. Consistent with this
migratory phenotype, we observed higher expression of genes
important for epithelial-mesenchymal transformation. Increased
expression of genes associated with extracellular matrix
Table 1. Summary of top 50 gene sets which showed
differential expression between hESC-VCMs and hF-VCMs.
hESC-VCM depleted # gene sets hESC-VCM enriched # gene sets
Cell Cycle 20 Cytokine and defense 17
Metabolism 9 Stress 6
Contraction 6 Movement 11
ROS metabolism 2 Signaling 3
Heart development 4 Development 1
Telomere 2 Apoptosis 1
Others 7 Others 11
doi: 10.1371/journal.pone.0077784.t001
organization e.g., COL2A1 was also noted although these latter
changes were not within the top 50 differentially gene sets.
Genes associated with cytokine stimulation and cellular
defense were also up-regulated in hESC-VCMs.
Novel expression changes in potassium and calcium
transport genes
Even though the electrophysiological attributes of hESC-CMs
are known to be immature [7-10,19], gene sets related to
potassium and calcium ion transport were not differentially
expressed between hESC-VCMs and hF-VCMs; however,
specific genes did show significant differences. Among Ca2+
transport genes, SLC8A1, PLN, RYR2, CACNB2, CAV3,
CAMK2A and CACNA1C levels were lower in hESC-VCMs, as
previously reported [14,18]. We also observed novel changes
in genes important for Ca2+ handling (Table 2). Sarcalumenin
(SRL) is a SR protein thought to regulate SERCA stability and
was reduced by 11.3-fold in hESC-VCMs. CAMK2D and
CAMK2B encode Ca2+/Calmodulin kinases (CAMKII) and
multiple isoforms of these genes were significantly reduced in
hESC-VCMs. Phospholemman (FXYD1) modulates Na+/K+
ATPase, INCX and ICa and was also highly reduced. Other genes
that were diminished included gap junction gene GJA4 (4.7-
fold), endothelin receptors, EDNRA (2.6-fold) and EDNRB (4.6-
fold), and CAV1 (2.8-fold) etc (Table 2). A comparison with hA-
VCMs further showed that most of these genes (CAMK2B,
CAMK2D, SRL, FXYD1 and ENDRB) were expressed at
increasing levels in hESC-, hF- and hA-VCMs, which supports
their potential role in cardiac maturation.
Table 2. Novel expression changes in genes involved in





CAMK2B 8.1, 5.5, 4.5,4.0* calcium/calmodulin-dependent protein kinase II beta
FXYD1 7.6, 5.4, 2.6* FXYD domain containing ion transport regulator 1(phospholemman)
CACNB2 5.3 calcium channel, voltage-dependent, beta 2 subunit
GJA4 4.7 gap junction protein, alpha 4, 37kDa
EDNRB 4.6 endothelin receptor type B
CAMK2D 3.7, 2.5* calcium/calmodulin-dependent protein kinase II delta
JAK2 3.3 Janus kinase 2 (a protein tyrosine kinase)
EPHX2 2.8 epoxide hydrolase 2, cytoplasmic
CAV1 2.8 caveolin 1, caveolae protein, 22kDa
KDR 2.7 kinase insert domain receptor
CSRP3 2.6 cysteine and glycine-rich protein 3 (cardiac LIMprotein)
PLCG2 2.6 phospholipase C, gamma 2 (phosphatidylinositol-specific)
EDNRA 2.6 endothelin receptor type A
*. Fold changes for multiple transcript variants of the same gene.
doi: 10.1371/journal.pone.0077784.t002
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We also detected novel expression changes in genes
encoding potassium channels, and consistent with previous
results, significantly reduced levels of KCNQ1, KCNE1,
KCNAB1, KCNJ2 and KCNJ8 were observed [14,18,28]. The
novel changes in potassium channels reported here are
implicated in cardioprotection and include genes encoding IKATP,
IKCa and IKNa (Table 3). Transcript variants for the regulatory unit
of IKATP, ABCC9, were either absent or reduced in hESC-VCMs
compared to hF-VCMs. Isoform-specific expression of IKCa
(KCNMB1 and KCNMB3) and IKNa (KCNT1 and KCNT2)
subunits were also observed. AQP1 (aquaporin-1) was
decreased in hESC-VCMs. KCNG1, KCTD8, FXYD2 and
KCNIP4 were uniquely expressed in hESC-VCMs.
Cardioprotective mechanisms in hESC-VCMs
IKATP, IKCa, IKNa, ROS metabolic enzymes and AQP1 are
important for cardioprotection by maintaining cellular
homeostasis. We postulated that reduced/perturbed expression
would result in increased susceptibility to injury. To test this, we
subjected hESC-VCMs to hypoxia and hypoxia/reoxygenation,
which is a model for ischemia/reperfusion injury. Consistent
with our postulate, we observed a 2-fold increase in TUNEL
positive apoptotic cells after hypoxia and hypoxia/
reoxygenation compared with normoxic conditions (Figure 3A).
By contrast, hF-VCMs showed almost no increase in cell death
after a similar protocol [29].
To further explore the mechanisms underlying this increased
cell vulnerability, we focused on the functionality of IKATP, which
regulates ion homeostasis in response to ATP depletion during
ischemic insult, and showed that IKATP was reduced in hESC-
VCMs. Sodium cyanide (CN) can induce ATP depletion via
uncoupling of oxidative phosphorylation. Application of CN
induced an outward current and significantly increased current
densities from 1.2+/-0.3 to 2.3+/-0.5 pA/pF, which was inhibited
by IKATP blocker glibenclamide (GLI) (Figure 3B). Of note, IKATP
in hESC-VCMs was smaller than that reported for hA-ACMs
(7.3 ± 2 pA/pF) [30] and mouse adult CMs (approx. 23 pA/pF)
[21]. Figure 3C further shows the role of IKATP in the AP
waveform. CN significantly reduced APD50 and APD90 to 61.0
and 56.7% of control, thereby hastening the spontaneous firing
(Figure 3D). CN had no significant effect on AP amplitude or
frequency (Figure 3D). This CN-mediated AP shortening could
be abolished by blockade of IKATP by GLI. In addition to ATP
depletion, ischemic insult is also accompanied by a cytosolic
buildup of metabolites, increased intracellular osmolarity,
followed by cell swelling. Given that IKATP and aquaporin-1 are
both involved in osmotic regulation, and their reduced
expression in hESC-VCMs may result in perturbed responses
to hypertonic stress (which simulates ischemic injury), we
tested the effect of hypotonic treatment on hESC-VCMs [22].
We found that hypotonic stress indeed resulted in the loss of
spontaneous AP in hESC-VCMs. 1000pA-5ms stimulation
produced an AP with significantly reduced APD50 and APD90
10.1% and 15.6% of control (Figure 3E and F). Upon recovery,
AP returned to pre-treatment conditions. Thus hESC-VCMs
were able to undergo AP shortening upon hypotonic treatment,
as was reported for adult guinea pig CMs [22].
Cardiac transcription factors: expression, co-
expression and promoter analyses
To unravel possible regulatory mechanisms for the
developmental immaturity of hESC-VCMs, we analyzed the
expression of transcription factors (TFs) critical for heart
development. We found that transcripts from TBX5 (12.9 fold),
TBX20 (6.9 fold), GATA4 (1.3 fold) and IRX5 (2.4 fold), which
are implicated in chamber formation [31-33], were reduced in
hESC-VCMs. Similarly, transcripts encoding critical cardiac
developmental TF genes, including HAND2 (3.0 fold), GATA6
(3.0 fold), IRX4 (2.6 fold), SRF (2.5 fold), were significantly
decreased. Conversely, TBX2 [34] and TBX3 [35] locally
repress chamber differentiation and TBX3 was 3-fold enriched
in hESC-VCMs. The expression of transcription factors ISL1,
MEF2C, MESP1, FOXP1, HAND1, NKX2.5 and PPARGC1A
were not significantly different between hESC-VCMs and hF-
VCMs.
We performed co-expression analysis to construct
transcriptional networks of cardiac TFs and genes important for
cardiac function [36]. First, we correlated the expression of
cardiac TFs across the four groups of sample, hESCs, hESC-
VCMs, hF-VCMs and hA-VCMs (Methods, Table S4) and found
that a group of 4 TFs consisting of HAND1, GATA4, NKX2-5
and PPARGC1A had significantly similar expression patterns
and that their expression also correlated highly and significantly
with a fifth TF, TCF8. HAND1, for instance, co-expressed with
GATA4, NKX2-5, PPARGC1A and TCF8 (Figure 4, Table S4).
Likewise, NKX2-5 also co-expressed with GATA4, HAND1,
PPARGC1A and TCF8. We then showed that these 5 TFs co-
expressed with many common genes, suggesting a co-
regulatory relationship between these 5 TFs and other genes in
Table 3. Novel expression changes in genes involved in
potassium ion transport and homeostasis, p<0.05.
Gene hF-VCM/ hESC-VCM Description
KCNT1 hF-VCM only potassium channel, subfamily T, member 1
ABCC9 hF-VCM only, 6.7,6.6*
ATP-binding cassette, sub-family C (CFTR/
MRP), member 9
KCNMB1 6.3 potassium large conductance calcium-activatedchannel, subfamily M, beta member 1
AQP1 3.0 aquaporin 1
CHP 2.1 calcium binding protein P22
NSF 0.5 N-ethylmaleimide-sensitive factor
KCNMB3 0.3 potassium large conductance calcium-activatedchannel, subfamily M beta member 3
NSF 0.2 N-ethylmaleimide-sensitive factor
KCTD8 hESC-VCM only potassium channel tetramerisation domaincontaining 8
KCNT2 hESC-VCM only potassium channel, subfamily T, member 2
KCNG1 hESC-VCM only potassium voltage-gated channel, subfamily G,member 1
FXYD2 hESC-VCM only FXYD domain containing ion transport regulator 2
KCNIP4 hESC-VCM only Kv channel interacting protein 4
*. Fold changes for multiple transcript variants of the same gene.
doi: 10.1371/journal.pone.0077784.t003
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Figure 3.  Functional analyses of hESC-VCMs.  A) Apoptotic response after hypoxia/reoxygenation was assessed using TUNEL
assay. HESC-VCMs were subjected to hypoxic treatment, followed by reoxygenation of different duration as indicated. *P<0.05
relative to normoxic conditions.
B) IKATP channel current and its effect on electrophysiological properties of hESC-VCMs. Representative current and summary of
current densities of whole-cell patch-clamp recording of hESC-VCMs. Extracellular application of IKATP channel openers, 2 mmol/L
sodium cyanide (CN), at 2 min significantly increased current densities compared to controls, which was inhibited by IKATP channel
blocker 10 uM glibenclamide (GLI). Cells were stimulated to 0 mV for 1000 ms from a holding potential of -80 mV preceded by a
100-ms prepulse to -10 mV. C) Representative tracings of action potentials of hESC-VCMs before and after treatment of 2 mM CN
and then 10 uM GLI. D) The effect of CN and GLI on APD50, APD90 and firing frequency. N=6; *P<0.05, **P<0.01 compared to
control group; #P<0.05, compared to CN group. Effect of hypotonic insult on hESC-VCMs. E) Representative tracings of action
potentials of hESC-VCMs before and after hypotonic insult, and upon recovery. F) The effect of hypotonic insult on APD50 and
APD90. N=6; **P<0.01 compared to control group.
doi: 10.1371/journal.pone.0077784.g003
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the microarray. HAND1, GATA4, NKX2-5, PPARGC1A and
TCF8 co-expressed with 144, 133, 172, 160 and 112 genes
respectively. These TFs also jointly co-expressed with many
common genes. For example, among 71 genes that showed
co-expression links with more than 5 of all 17 TFs, 39 co-
expressed with HAND1, GATA4, NKX2-5, PPARGC1A and
TCF8. In addition, 19 of these co-expressed exclusively with
the 5 TFs, indicating that these TFs are major components of
such a co-expressed gene network. Although we identified a
relatively large number of co-expressed genes with MEF2C
(108), MESP1 (73) and PPARA (97), they did not form co-
expression links with other TFs. The other 8 TFs co-expressed
with far fewer genes (below 51).
The gene ontology affiliations of genes which co-expressed
with the 5 TFs were primarily associated with Ca2+
homeostasis, contraction, metabolism and transcriptional
regulation. Totally, 39 genes had a co-expression relationship
with all 5 TFs. Of these, seven (MYH7, SMPX, TNNT2, MYL2,
TNNC1, CSRP3 and FHL2) are involved in contraction/
cytoskeleton (Figure 4). The rest included TFs (KLF2 and
ZMYND11), and regulators of the AMPK pathway PRKAA1 and
PRKAG2, etc. 88 genes correlated with at least 4 of the 5 TFs,
including themselves HAND1 and NKX2-5 (Table S4). These
analyses were then extended to develop a co-expression
network, that bioinformatically shows highly significant and
conserved patterns of expression between TFs and putative
target genes. The resulting co-expression network consisted of
genes associated with transcriptional regulation, contraction,
metabolism and calcium handling processes and consisted of 5
TFs and 22 putative target genes (Figure 4).
We further defined the regulatory structure of our co-
expression network by examining the promoter regions of all 27
genes for binding sites of 4 TFs (GATA4, HAND1, NKX2-5 and
TCF8) (Table 4, Table S5 for details). PPARGC1A was
excluded from analysis because it mostly functions as a co-
factor and does not have defined binding sites. Our analysis
identified many binding sites for the 4 TFs among the
promoters of the 27 genes. GATA4, HAND1, NKX2-5 and
Figure 4.  Co-expression network in CMs.  The five transcription factors are shown as hexagons with gene symbols and their
connections are shown by solid lines of the same colors e.g. GATA4 is in red and are connected to co-expressed genes by solid red
lines. Genes are shown in circles and are color-coded to indicate their functional classifications. Red = regulation of contraction/
adhesion, yellow = AMP kinases, blue = contractile genes, white = transcription factors, green = Ca/calmodulin kinases, purple = Ca
handling protein. Gene labels in purple indicate genes that are co-expressed with all five transcription factors. Gene labels in black
indicate genes that are co-expressed with three or four transcription factors.
doi: 10.1371/journal.pone.0077784.g004
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TCF8 predicted binding sites were found in the promoter
regions of 9, 10, 23, 22 genes respectively. Many genes
contained binding sites for multiple TFs in their promoters. 22
out of 27 genes contained binding sites for 2 or more TFs in
their promoters, consistent with a regulatory relationship
between the TFs analysed and the other genes in the co-
expression network. Additionally, the TFs themselves were
predicted to regulate each other. For instance, HAND1
promoter contained binding sites for all 4 TFs (GATA4,
HAND1, NKX2-5 and TCF8). This is consistent with the co-
expression relationship between HAND1 and GATA4, NKX2-5,
PPARGC1A and TCF8.
Discussion
Here, we describe the transcriptome of hESC-VCMs and
compare them with their in vivo counterparts to evaluate their
molecular phenotype and developmental status and to identify
regulatory mechanisms that might underlie these differences.
Our PCA results show that hESC-VCMs are developmentally
less advanced than hF-VCMs of 18-20 weeks. In support of the
above assertion, we also show that the expression of genes
important for CM function (e.g. contraction, metabolism and
heart development) are low in hESC-VCMs. Similar results
have been reported between non-purified/mixed lineage hESC-
Table 4. Promoter analysis.
Gene GATA4 HAND1 NKX2.5 TCF8
ACTC1   2  
CAMK2A   2 1
CAMK2D  1 2 1
CSRP3 1 1 5 1
FHL2 1  8 3
GATA4     
HAND1 1 1 1 1
KLF2   3  
LAMA4  1  1
MYBPC3   2 1
MYH7   2 1
MYL2   2 1
MYL3  2 4 2
MYL9  1   
MYOM1 1  4 1
NKX2-5   2 3
PLN 2  5 3
PPARGC1A 1  3 1
PRKAA1   2 1
PRKAG2  1 4 2
SMPX  2 2 1
TMOD1   3 1
TNNC1  1 2 2
TNNT2   1  
TPM1 1 1  1
ZEB1 1  1 2
ZMYND11 2  2 3
doi: 10.1371/journal.pone.0077784.t004
CMs and/or whole fetal heart, but it was unclear whether these
results were due to contaminating fibroblasts in whole fetal
heart and/or the presence of pacemaker/atrial/ventricular cells
in hESC-CM cultures [14,17]. Here we showed that ventricular-
specific hESC-CMs are less mature than hF-CMs of 18-20
weeks. Consistent with our findings, He et al. claim that hESC-
derived beating outgrowths have properties of APs anticipated
in embryonic heart before 7 weeks of development [2]. Our
staging, however, differs from that of Cao et al [14] who stated
that hESC-derived cultures were most similar to 20 weeks old
hF-VCMs. Such differences could be attributed to the limited
enrichment of hESC-CMs in their cultures, which consisted of
only 40-45% CMs. Consistent with this, hierarchical clustering
showed that their enriched hESC-CMs were grouped more
closely with embryoid bodies (consisting of a mixed cell
population) than hF-VCMs. We also uniquely show that hESC-
VCMs expressed markers of, and had low conduction velocity
consistent with immature chamber myocardium [23]. Two
groups have previously measured the conduction velocity of
non-purified beating hESC-CMs clusters [11,37]. However, the
results were heterogeneous and the authors indicated that this
may partly stem from the presence of non-myocytes within the
cell network which may electrically couple with CMs and
thereby slow conduction [37]. We show that purified hESC-
VCMs indeed had a conduction velocity(5.0±1.4 cm/s) much
slower than that of adult human heart [25].
16% of genes are differentially expressed between hESC-
VCMs and hF-VCMs by more than 2-fold. Interestingly, this
16% difference accounts for a 49% difference among gene
sets as examined by GSEA, partly because differential
expression of the same genes can contribute to the enrichment
of multiple gene sets (e.g., CCNB1 was found in 20 gene sets
upregulated in hF-VCMs). An examination of gene sets
(defined by function) rather than individual genes gives a more
comprehensive overview of transcriptional differences among
hESC-VCMs and hF-VCMs. By applying this approach, we
confirm expression changes in contractile, fatty acid metabolic
genes using our ventricular-specific system. In addition, we
uniquely show that hESC-VCMs expressed lower levels of cell
cycle and ROS metabolic genes and higher levels of genes
associated with migration. In the setting of acute myocardial
infarction, ROS is implicated in tissue necrosis and reperfusion
injury [38]. Therefore, mechanisms that promote ROS enzyme
up-regulation would be important to promote cell survival in the
context of cell therapy. We found that hESC-VCMs expressed
significantly lower levels of genes involved in cell cycle
progression and telomere maintenance while genes involved in
cellular senescence and apoptosis are up-regulated. It should
be noted that proliferation of hESC-CMs can be affected by
culture conditions [39]. Migration-related genes, however, are
up-regulated in hESC-VCMs. Embryonic heart development
involves complex morphogenic progression to transform the
linear tube to a four-chambered heart. Thus, the motile
phenotype of hESC-VCMs may reflect that of early embryonic
CMs and may mean better abilities to home and migrate to
injured sites for transplantation therapy.
We and others have reported that hESC-CMs display
immature Ca2+ transient properties [8] and exhibit other defects
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such as a negative force-frequency response [40] and a lack of
positive inotropy upon β-adrenergic stimulation [41]. Here, we
have identified molecules which are dramatically down-
regulated in hESC-VCMs and which may underlie the above
defects. CAMKII is critically involved in the regulation of Ca2+
homeostasis through phosphorylation of Ca2+ handling proteins
such as PLN [42] and RyR [43] and also participates in force-
frequency response [43]. Other down-regulated genes include
FXYD1 (phospholemman) and SRL (sarcalumenin), which can
regulate Ca2+ transient properties and modulate adrenergic
stimulation [44,45]. In addition, sarcalumenin was among the
200 most abundant genes in hF-VCMs and hA-VCMs and was
11-fold lower in hESC-VCMs. Our group has previously shown
that over-expression of calsequestrin, a Ca2+-handling protein
absent in hESC-VCMs, can facilitate CM maturation [46]. The
genes identified here represent new possible targets for
mechanism-based maturation strategies.
One of the major applications of hESC-CM research is to
transplant these in vitro generated CMs into infarcted heart to
repair damaged myocardium. Laflamme et al has previously
shown that hESC-CM survival is significantly lower when
transplanted into infarcted rat heart compared to uninjured
heart and that the addition of pro-survival factors is required to
improve graft survival [47]. Understanding factors that regulate
hESC-VCM survival under ischemic environment is therefore
crucial for hESC-VCM transplantation therapy. Here, we show
that hESC-VCMs express lower levels of cardioprotective
molecules that regulate ROS metabolism, IKATP, IKNa and IKCa etc
and are correspondingly more vulnerable to hypoxia/
reoxygenation injury than hF-VCMs. We also confirmed by
functional analysis that IKATP was depleted in hESC-VCMs
compared to adult CMs. Factors that upregulate these
molecules would therefore be of benefit to the use of hESC-
VCMs in regenerative medicine. Another potential application
for hESC-CMs is to use these cells as in vitro test beds for
detecting pro-arrhythmic and/or cardiotoxic drugs [48,49]. Our
hESC-VCMs express reduced levels of important channels and
Ca2+ handling genes eg KCNJ2 and PLN etc, consistent with
previous publications [8,17,50]. On a multicellular level, the
random arrangement of CX43 and low conduction velocity
reported here are also in line with our recent paper showing
that the conduction pattern of hESC-VCMs cultured on 2-
dimensional surfaces are immature and isotropic [51].
Successful drug testing requires that hESC-VCMs exhibit
electrophysiological and survival properties similar to adult
CMs in vivo. Here we demonstrate that the expression and
function of specific ion channels and cardioprotective
molecules are perturbed in hESC-VCMs compared to their in
vivo counterparts. Although hESC-CMs may still have
advantages over current cell models such as primary canine or
rabbit Purkinje fibers or cell lines ectopically expressing the
hERG ion channel, we urge that results of tests involving
hESC-CMs be treated with caution as we recently reviewed
[52].
Embryonic heart development involves the coordinate action
of many TFs. To unravel these complex actions, we employed
bioinformatics co-expression and promoter analyses. Our
analyses suggest that genes involved in transcriptional
regulation, contraction, energy metabolism and calcium
homeostasis may be co-regulated on a transcriptional level.
Interestingly, many genes identified in our network are already
related via post-translational regulation or protein interaction,
for example, CAMKII phosphorylates PLN to regulate Ca2+
homeostasis, which in turn determines contractile activity by
modulating troponin/tropomyosin interaction. The co-
expression of these molecules suggests that they may be
commonly regulated on the mRNA (as well as protein) level.
Our promoter analysis further reveals that HAND1, GATA4,
NKX2-5 and TCF8 binding sites are present in the promoters of
the majority of genes in the co-expression network, suggesting
a regulatory relationship between these TFs and their putative
target genes. We speculate that the five TFs (HAND1, GATA4,
NKX2-5, PPARGC1A and TCF8) may play a role in the
regulation of diverse processes important for cardiac function,
however, only four of these TFs are known to be critical to
heart development or function. GATA4 regulates the
expression of MYH7(βMHC) [53] and acts synergistically with
NKX2.5 to activate downstream targets [31]. The importance of
these TFs is underscored by transgenic studies, which shows
that null deletions of Gata4, Nkx2.5 or Hand1 arrest cardiac
development in vivo. PPARGC1A is a co-regulator of the PPAR
pathway, and is important for metabolic activity [54]. The fifth
member of the group, TCF8, has not previously been
associated with heart development and function. Mice null for
Tcf8 had no reported heart abnormality [55]. In summary, we
uncovered a transcriptional hierarchy involving 5TFs and genes
important for CM development and function, and we postulate
these 5 TFs may be crucial for hESC-CM maturation.
Consistent with this, perinatal loss of Nkx2-5 in mice results in
reduced contractile and Ca2+-handling parameters which are
accompanied by decreased ion channel expression [56], and
this is reminiscent of the contractile and electrophysiological
defects of hESC-CMs. Agents that up-regulate these TFs may
promote hESC-CM maturation in vitro.
Conclusion
Differentiation of hESC into CMs can potentially represent an
unlimited cell source for disease modeling and cell based
therapies. However, caution should be taken to ensure their
safety by comparing these in vitro generated CMs with in vivo
standards. HESC-VCMs generated using current protocols are
functionally immature and are vulnerable to injury. Mechanism-
based in vitro maturation strategies would be crucial to facilitate
the translation of hESC-CMs into clinical applications.
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